Lanean...
Diabetes and the kidney
Diabetes is the most common cause of end-stage kidney disease. Randomised controlled trials have shown a significant benefit of sodium-glucose transporter-2 inhibitors in patients with diabetic kidney disease (DKD), and guidelines now suggest these drugs should be considered in all patients with DKD...
Gorde:
| Argitaratua izan da: | Clin Med (Lond) |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Royal College of Physicians
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8313217/ https://ncbi.nlm.nih.gov/pubmed/35192470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmed.2021-0144 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|